Global Biosimilar Monoclonal Antibodies Competitive Landscape Professional Research Report 2024

Research Summary

Biosimilar monoclonal antibodies are therapeutic proteins that are highly similar to existing monoclonal antibodies, which are designed to target specific disease-causing molecules in the body. Biosimilar monoclonal antibodies are created through a complex manufacturing process that involves the use of living cells to produce proteins that mimic the structure and function of the original antibody. These biosimilars undergo rigorous testing to demonstrate similarity in terms of efficacy, safety, and quality compared to the reference monoclonal antibody. They offer the potential for more affordable and accessible treatment options for patients, as they can be approved as alternatives to expensive brand-name monoclonal antibodies once their patents expire.

According to DIResearch's in-depth investigation and research, the global Biosimilar Monoclonal Antibodies market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Biosimilar Monoclonal Antibodies include Biocon, Accord Healthcare, AET Biotech, Amgen, Celltrion, Reddy's Laboratories, Hospira, 3SBio, Allergan, Alvartis etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Biosimilar Monoclonal Antibodies. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biosimilar Monoclonal Antibodies market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biosimilar Monoclonal Antibodies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biosimilar Monoclonal Antibodies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Biosimilar Monoclonal Antibodies Include:

Biocon

Accord Healthcare

AET Biotech

Amgen

Celltrion

Reddy's Laboratories

Hospira

3SBio

Allergan

Alvartis

Biosimilar Monoclonal Antibodies Product Segment Include:

Limited Dilution Method

Micromanipulation

Soft Agar Plate Method

Others

Biosimilar Monoclonal Antibodies Product Application Include:

Chronic & Autoimmune Diseases

Oncology

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Biosimilar Monoclonal Antibodies Industry PESTEL Analysis

Chapter 3: Global Biosimilar Monoclonal Antibodies Industry Porter's Five Forces Analysis

Chapter 4: Global Biosimilar Monoclonal Antibodies Major Regional Market Size and Forecast Analysis

Chapter 5: Global Biosimilar Monoclonal Antibodies Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Biosimilar Monoclonal Antibodies Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Biosimilar Monoclonal Antibodies Market Overview

1.1 Product Definition and Statistical Scope

1.2 Biosimilar Monoclonal Antibodies Product by Type

1.2.1 Global Biosimilar Monoclonal Antibodies Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Limited Dilution Method

1.2.3 Micromanipulation

1.2.4 Soft Agar Plate Method

1.2.5 Others

1.3 Biosimilar Monoclonal Antibodies Product by Application

1.3.1 Global Biosimilar Monoclonal Antibodies Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Chronic & Autoimmune Diseases

1.3.3 Oncology

1.3.4 Others

1.4 Global Biosimilar Monoclonal Antibodies Market Revenue Analysis (2019-2030)

1.5 Biosimilar Monoclonal Antibodies Market Development Status and Trends

1.5.1 Biosimilar Monoclonal Antibodies Industry Development Status Analysis

1.5.2 Biosimilar Monoclonal Antibodies Industry Development Trends Analysis

2 Biosimilar Monoclonal Antibodies Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Biosimilar Monoclonal Antibodies Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Biosimilar Monoclonal Antibodies Market Analysis by Regions

4.1 Biosimilar Monoclonal Antibodies Overall Market: 2023 VS 2024 VS 2030

4.2 Global Biosimilar Monoclonal Antibodies Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2019-2024)

4.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2025-2030)

5 Global Biosimilar Monoclonal Antibodies Market Size by Type and Application

5.1 Global Biosimilar Monoclonal Antibodies Market Size by Type

5.2 Global Biosimilar Monoclonal Antibodies Market Size by Application

6 North America

6.1 North America Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Biosimilar Monoclonal Antibodies Market Size by Type

6.4 North America Biosimilar Monoclonal Antibodies Market Size by Application

6.5 North America Biosimilar Monoclonal Antibodies Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Biosimilar Monoclonal Antibodies Market Size by Type

7.4 Europe Biosimilar Monoclonal Antibodies Market Size by Application

7.5 Europe Biosimilar Monoclonal Antibodies Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Biosimilar Monoclonal Antibodies Market Size by Type

8.4 China Biosimilar Monoclonal Antibodies Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Type

9.4 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Application

9.5 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Biosimilar Monoclonal Antibodies Market Size by Type

10.4 Latin America Biosimilar Monoclonal Antibodies Market Size by Application

10.5 Latin America Biosimilar Monoclonal Antibodies Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Type

11.4 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Application

11.5 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Biosimilar Monoclonal Antibodies Market Revenue by Key Manufacturers (2020-2024)

12.2 Biosimilar Monoclonal Antibodies Competitive Landscape Analysis and Market Dynamic

12.2.1 Biosimilar Monoclonal Antibodies Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Biocon

13.1.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Biocon Biosimilar Monoclonal Antibodies Product Portfolio

13.1.3 Biocon Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Accord Healthcare

13.2.1 Accord Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Accord Healthcare Biosimilar Monoclonal Antibodies Product Portfolio

13.2.3 Accord Healthcare Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 AET Biotech

13.3.1 AET Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 AET Biotech Biosimilar Monoclonal Antibodies Product Portfolio

13.3.3 AET Biotech Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Amgen

13.4.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Amgen Biosimilar Monoclonal Antibodies Product Portfolio

13.4.3 Amgen Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Celltrion

13.5.1 Celltrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Celltrion Biosimilar Monoclonal Antibodies Product Portfolio

13.5.3 Celltrion Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Reddy's Laboratories

13.6.1 Reddy's Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Reddy's Laboratories Biosimilar Monoclonal Antibodies Product Portfolio

13.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Hospira

13.7.1 Hospira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Hospira Biosimilar Monoclonal Antibodies Product Portfolio

13.7.3 Hospira Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 3SBio

13.8.1 3SBio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 3SBio Biosimilar Monoclonal Antibodies Product Portfolio

13.8.3 3SBio Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Allergan

13.9.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Allergan Biosimilar Monoclonal Antibodies Product Portfolio

13.9.3 Allergan Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Alvartis

13.10.1 Alvartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Alvartis Biosimilar Monoclonal Antibodies Product Portfolio

13.10.3 Alvartis Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Biosimilar Monoclonal Antibodies Industry Chain Analysis

14.2 Biosimilar Monoclonal Antibodies Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Biosimilar Monoclonal Antibodies Typical Downstream Customers

14.4 Biosimilar Monoclonal Antibodies Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support